1. 1. Loeffler JS, Durante M. Charged particle therapy—optimization, challenges and future directions. Nat Rev Clin Oncol; 2013. 10:411-24.
2. 2. Kempe I, Gudowska I, Brahme A. Depth absorbed dose and LET distributions of therapeutic 1H, 4He, 7Li, and 12C beams. Med Phys; 2007. 34:183-92.
3. 3. Kantemiris I, Karaiskos P, Papagiannis P, Angelopoulos A. Dose and dose averaged LET comparison of (1)H, (4)He, (6)Li (8)Be, (1)(0)B, (1)(2)C, (1)(4)N, and (1)(6)O ion beams forming a spread-out Bragg peak. Med Phys; 2011. 38: 6585-1.
4. 4. Pshenichnov I, Mishustin I, Greiner W. Comparative study of depth–dose distributions for beams of light and heavy nuclei in tissue-like media. Nucl Instrum Methods Phys Res B; 2008. 266:1094-8.
5. 5. Romano F, Cirrone GA, Cuttone G, Rosa FD, Mazzaglia SE, Petrovic I, et al. A Monte Carlo study for the calculation of the average linear energy transfer (LET) distributions for a clinical proton beam line and a radiobiological carbon ion beam line. Phy Med Bio; 2014. 59: 2863-82.
6. 6. Tessonnier T, Mairani A, Chen W, Sala P, Cerutti F, Ferrari A, et al. Proton and helium ion radiotherapy for meningioma tumors: a Monte Carlo-based treatment planning comparison. Rad Oncol; 2018. 3:12-7.
7. 7. Fuchs H, Strobele J, Schreiner T, Hirtl A, Georg D. A pencil beam algorithm for helium ion beam therapy. Med Phys; 2012. 39:6726-37.
8. 8. Kurz C, Mairani A, Parodi K. First experimental-based characterization of oxygen ion beam depth dose distributions at the Heidelberg Ion-Beam Therapy Center. Phys Med Biol; 2012. 57:5017-34.
9. 9. Tommasino F, Scifoni E, Durante M. New ions for therapy. Int J Particle Ther; 2015. 428-38.
10. 10. Mortazavi SMJ, Hosseini SMA, Jia SB, Mahdavi SR, Mehdizadeh AR. A scientific review on hadron therapy. Razi J Med Sci; 2017. 23:52-67.
11. 11. Bortfeld T, Schlegel W. An analytical approximation of depth–dose distributions for therapeutic proton beams. Phy Med Bio; 1996. 41:1331-9.
12. 12. Rezaee L. Design of spread-out Bragg peaks in hadron therapy with oxygen ions. Rep Prac Oncol Rad; 2018. 23:433-41.
13. 13. Schultheiss TE, Zagars GK, Peters LJ. An explanatory hypothesis for early-and late-effect parameter values in the LQ model. Radiother Oncol; 1987. 9:241.
14. 14. Kramer M, Scholz M. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning. Phy Med Bio; 2000. 45:3319.
15. 15. Habermehl D, Ilicic K, Dehne S, Rieken S, Orschiedt L, Brons S, et al. The relative biological effectiveness for carbon and oxygen ion beams using the raster-scanning technique in hepatocellular carcinoma cell lines. Plos One; 2014. 9:113591.
16. 16. Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear
17. energy transfer. Phy Med Bio; 2014. 59:419.
18. 17. Agostinelli S, Allison J, Amako K. Geant4—a simulation toolkit. Nucl Instr Meth Phys Res A; 2003. 506:250-303.
19. 18. Zirkle RE, Marchbank DF, Kuck KD. Exponential and sigmoid survival curves resulting from alpha and X irradiation of aspergillus spores. J Cellular Com Physiol; 1952. 39:75.
20. 19. Grzanka L. Modelling beam transport and biological effectiveness develop treatment planning for ion beam radiotherapy. PhD Thesis. 2013.
21. 20. Scholz M, Kellerer AM, Kraft-Weyrather W, Kraft G. Computation of cell survival in heavy ion beams for therapy. The model and its approximation, Radiat Environ Biophys; 1997. 36:59.
22. 21. Kelley MR. DNA repair in cancer therapy: molecular targets and clinical applications. Amsterdam: Academic Press; 2012.
23. 22. Tessonnier T. Treatment of low-grade meningiomas with protons and helium ions. PhD Thesis. 2017.
24. 23. Yuki K, Kanematsu N, Kanai T, Matsufuji N. Biological dose calculation with Monte Carlo physics simulation for heavy-ion radiotherapy. Phy Med Bio; 2006. 51:467-75.
25. 24. Hosseini MA, Jia SB, Ebrahimi-Loushab M. Analysis of relative biological effectiveness of proton beams and isoeffective dose profiles using Geant4. J Biomed Phys Eng; 2017. 7:95-100.
26. 25. Jette D, Chen W. Creating a spread-out Bragg peak in proton beams. Phy Med Bio; 2011. 56:131-8.
27. 26. Słonina D, Biesaga B, Swakoń J, Kabat D, Grzanka L, Ptaszkiewicz M, et al. Relative biological effectiveness of the 60-MeV therapeutic proton beam at the Institute of Nuclear Physics (IFJ PAN) in Kraków, Poland. Radiat Environ Biophys; 2014. 53:745.
28. 27. Bert C, Engenhart-Cabillic R, Durante M. Particle therapy for noncancer diseases. Med Phy; 2012. 39:1716-27.